Local adverse events during long term treatment with implantable insulin pumps in type I diabetic patients

被引：0

作者：

Jeandidier, N

Belicar, P

Boivin, S

Pinget, M

机构：

[1] HU STRASBOURG,SERV ENDOCRINOL,STRASBOURG,FRANCE

[2] HOP ENFANTS LA TIMONE,SERV MED INTERNE,MARSEILLE,FRANCE

来源：

DIABETOLOGIA | 1997年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1402 / 1402

页数：1

共 50 条

[1] Local adverse events associated with long-term treatment by implantable insulin pumps
Belicar, P
Lassmann-VAgue, V
DIABETES CARE, 1998, 21 (02) : 325 - 326
[2] Antiinsulin antibody (AIA) evolution during long term implantation and after explantation of implantable pumps using intraperitoneal insulin infusion in type 1 diabetic patients
不详
ACTA DIABETOLOGICA, 2005, 42 (01) : 49 - 49
[3] LONG-TERM TREATMENT OF TYPE-I DIABETES IN 28 PATIENTS USING 2 DIFFERENT IMPLANTABLE PROGRAMMABLE PUMPS
JEANDIDIER, N
PINGET, M
KEIPES, M
LOUY, S
CHARTON, MN
MARESCAUX, J
REVILLE, P
TRANSPLANTATION PROCEEDINGS, 1992, 24 (03) : 940 - 941
[4] INSULIN STABILITY AND IMMUNOGENICITY DURING LONG-TERM INTRAPERITONEAL IMPLANTABLE PROGRAMMABLE PUMP TREATMENT IN TYPE-I DIABETES
JEANDIDIER, N
SELAM, JL
SAUDEK, CD
NAGY, M
ZOLTOBROCKI, M
CHARLES, MA
CLINICAL RESEARCH, 1989, 37 (01): : A159 - A159
[5] What about anti insulin immunogenicity on a long term in diabetic patients treated with implantable insulin pump?
Belicar, P
LassmannVague, V
Alessis, C
Vague, P
DIABETOLOGIA, 1997, 40 : 1324 - 1324
[6] Long term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps
Pinget, M
Jeandidier, N
HORMONE AND METABOLIC RESEARCH, 1998, 30 (08) : 475 - 486
[7] Are catheter occlusions related to insulin immunogenicity during treatment by implantable pumps?
Belicar, P
LassmannVague, V
RojatHabib, MC
Pellissier, JF
Alessis, C
Vague, P
DIABETOLOGIA, 1996, 39 : 813 - 813
[8] RANDOMIZED COMPARISON OF METABOLIC CONTROL ACHIEVED BY INTRAPERITONEAL INSULIN INFUSION WITH IMPLANTABLE PUMPS VERSUS INTENSIVE SUBCUTANEOUS INSULIN THERAPY IN TYPE-I DIABETIC-PATIENTS
SELAM, JL
RACCAH, D
JEANDIDIER, N
LOZANO, JL
WAXMAN, K
CHARLES, MA
DIABETES CARE, 1992, 15 (01) : 53 - 58
[9] IMPLANTATION OF PROGRAMMABLE INFUSION PUMPS FOR INSULIN DELIVERY IN TYPE-I DIABETIC-PATIENTS
WALTER, H
GUNTHER, A
KRONSKI, D
FLASCHENTRAGER, T
MEHNERT, H
KLINISCHE WOCHENSCHRIFT, 1989, 67 (11): : 583 - 587
[10] Long term treatment with insulin-stimulating agent, nateglinide, ameliorates insulin resistance in type 2 diabetic patients
Inukai, Kouichi
Nakashima, Youhei
Ikegami, Yuichi
Imai, Kenta
Awata, Takuya
Katayama, Shigehiro
DIABETES, 2006, 55 : A483 - A483

← 1 2 3 4 5 →